Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adrian Rawcliffe Insider Profile
4 Followers
Adrian Rawcliffe, CEO, Director at Adaptimmune Therapeutics, holds 16.11K shares in Wave Life Sciences (Ticker: WVE), holds 44.85K shares in Adaptimmune Therapeutics (Ticker: ADAP).
Adrian Rawcliffe has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Adrian Rawcliffe holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 22, 2018 - Mar 22, 2019
Return:+68.30%
The most profitable trade made by Adrian Rawcliffe
Adrian Rawcliffe's Trading History
Adaptimmune Therapeutics
Jan 17, 2024
CEO, Director
Uninformative Sell
27.50K
$37.22K
Wave Life Sciences
Aug 14, 2024
Director
Uninformative Buy
―
$223.03K
List of latest transactions for each holding click on a transaction to see Adrian Rawcliffe's performance on stock
You May Also Like
Adrian Rawcliffe insider profile FAQ
What is the percentage of profitable transactions made by Adrian Rawcliffe?
The percentage of profitable transactions made by Adrian Rawcliffe is ―.
What is the average return per transaction made by Adrian Rawcliffe?
The average return per transaction made by Adrian Rawcliffe is ―.
What stocks does Adrian Rawcliffe hold?
Adrian Rawcliffe holds: ADAP, WVE stocks.
What was Adrian Rawcliffe’s latest transaction?
Adrian Rawcliffe latest transaction was an Uninformative Buy of ―.
What was Adrian Rawcliffe's most profitable transaction?
Adrian Rawcliffe’s most profitable transaction was an Informative Sell of ADAP stock on March 22, 2018. The return on the trade was 68.30%.
What is Adrian Rawcliffe's role in Adaptimmune Therapeutics?
Adrian Rawcliffe's role in Adaptimmune Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.